For Healthcare Professionals
Advice for prescribers and other HCPs supporting patients on the correct use of AAIs and what to do in an anaphylaxis emergency.
On 19 June 2023, the MHRA, with the support of allergy awareness advocates launched a safety campaign to raise awareness of anaphylaxis and provide advice on the use of AAIs. The launch coincided with World Allergy Week; an annual initiative led by the World Allergy Organization.
A toolkit of resources is available for health and social care professionals to support the safe and effective use of AAIs.
The resources are freely available and include an infographic about the correct use of an AAI. Use the materials to inform patients and caregivers what to do if they suspect anaphylaxis and how to use AAIs. Prescribers should prescribe two AAIs to make sure patients always have a second dose.
Talk to your colleagues about the safe use of AAIs and the signs of anaphylaxis using the mnemonic A,B,C for Airway, Breathing and Circulation.
Report any suspected defective AAIs to the Yellow Card scheme. Keep defective AAIs for investigation. Your report improves the safety of medicines and medical devices. When reporting suspected adverse drug reactions, please provide as much information as possible, including information about medical history, any concomitant medication, onset timing, and treatment dates. When reporting please ensure that you provide the brand name (or product licence number and manufacturer), and the specific batch number.